Oxford Endovascular Analysis: $20M Raised
What is Oxford Endovascular?
Oxford Endovascular develops a novel flow-diverter to treat brain aneurysms, aiming to prevent brain hemorrhage. The device is designed for improved accuracy and safety compared to existing solutions, addressing a significant clinical need in a market exceeding $1 billion. The company has secured over $10 million in funding, including a Horizon 2020 grant from the European Union.
Location
9400 Garsington Road, Oxford Business Park, Oxford, United Kingdom OX4 2HN
Employees
1-10
Founded
2015
Funding Status
Seed
Product Features & Capabilities
- Next-generation flow-diverter for intracranial aneurysms
- Proprietary origami-engineered medical device
- Clinical trials for first-in-human data
Use Cases
Divert blood flow from aneurysms at risk of rupture; Treat patients with complex vascular anatomies; Reduce complications associated with existing devices; Improve patient outcomes in neurovascular procedures; Support clinical research in neurovascular disease
HQ Full Address
9400 Garsington Road, Oxford Business Park, Oxford, United Kingdom OX4 2HN
Other Considerations
Raised over $10 million in funding; Received Horizon 2020 grant for innovation; Patented technology in Europe, US, China, and Japan
See something that needs updating? Suggest edits to this profile.